ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FDBK Feedback Plc

97.50
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 97.50 95.00 100.00 97.50 97.50 97.50 5,188 07:36:53
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -4.46 13M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 97.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £13 million. Feedback has a price to earnings ratio (PE ratio) of -4.46.

Feedback Share Discussion Threads

Showing 13751 to 13772 of 14800 messages
Chat Pages: Latest  556  555  554  553  552  551  550  549  548  547  546  545  Older
DateSubjectAuthorDiscuss
07/11/2022
19:39
Have any of the “partnerships” enhanced Bleepa to date Ged?
ducatiman
07/11/2022
14:42
In October 2020 FDBK announced a partnership with Axial3D.

"The commercial agreement will enable joint- and cross-selling of both products through each company's distribution channels to new and existing customers, enabling both organisations to grow collaboratively. Under the agreement Feedback will receive a commission for each user-generated image request from Axial3D. This is the first example of the Company's strategy to leverage its growing userbase to generate supplementary revenue, over and above the main user licence fee."



Last week Axial announced a partnership with Stratasys. Will this enhance the Bleepa product? I'd like to think so and in an ideal world it probably would.

ged5
06/11/2022
20:08
Wiggle?.

BWTFDIK

sideshowbull
04/11/2022
11:38
Harrogate Duc.
lr2
04/11/2022
10:29
Twenty quid Pete, on current form 20p looks more likely. The market isn’t believing the story. Something positive needed soon for sure.
ducatiman
03/11/2022
21:55
Mobile site never picks up the header from any thread and I just click the ADVFN financials button to get the basic info, which looks all okay to me.
Good info earlier even though I do not understand what ‘approval̵7; means in this case.
Why on god’s earth does Tom not update the market on these little milestones and give us something to chew on. Surely, he cannot claim confidentiality since this is out in the public domain.
Either it means jack all or Tom will deliver a blockbuster before Christmas and the price will soar to twenty quid.

petekand
03/11/2022
09:54
Good morning, LR2 and thanks. Let's hope some contracts come from all this work.

Roadshow at Cardiff this morning so more exposure.

Pete, I've put the Fundamental Data back in the header. Works fine on my laptop but noticed it doesn't appear on my phone.

ged5
03/11/2022
09:13
Courtesy of OldTramp over on the other place.



Go to page 173 for details. Also a mention on page 192 but referred to as Bleeper not Bleepa.
____________________________

Referrals continue to be received through the digital platform Bleepa (which
connects QVH with primary and secondary care colleagues), for the
breathlessness pathway. This is working extremely well, the patient
outcome and feedback received from both patients and GP’s is positive.
• Patient feedback using LIME survey to gather patient feedback and
experience of the pathway is underway, although numbers are small as
patient feedback received via email only. Due to the cohort of patients
within this pathway digital access can be challenging, this survey can now
be sent to patients via text where appropriate. This will hopefully increase
the number of responses received, as currently this is very low.
• The Full Business Case (FBC) has been submitted to NHSE and has
approval in principle. There are several queries requested, responses to
this are underway with the team, due for submission 17 October 2022.
• Working with the CDC team to open up to individualised tests at the
beginning of November 2022 for physiological tests.

lr2
02/11/2022
15:01
Sorted Ged.
petekand
02/11/2022
14:05
Rishi reckons no NHS budget cuts will be made but efficiencies will be found.
Ged, I’ll send a third message to ADVFN, hopefully yesterdays RNS will make their job easier.

petekand
02/11/2022
08:57
Oh dear....
ydderf
01/11/2022
15:45
Exciting isn't it?
lr2
01/11/2022
15:38
Got interested for a second.
ged5
01/11/2022
13:09
Wiggly? Interesting way to describe it.

There's hardly any volume at the moment to make it worthwhile. News needed.

ged5
30/10/2022
18:40
Doing my friends rounds, chart will never work properly after the squeeze, but happy to do a hybrid one.

I am not sure it is a good idea yet as market is very wiggly.

BWTFDIK

sideshowbull
30/10/2022
16:02
Ged, England RL haven’t been tested, neither have NZ or the Kangaroos. Qtr finals start next Friday, then it gets interesting. Pool games are all about giving emerging nations experience and an experience!
LR2, I will just hold tight but if even 10% of the “addressable market” is addressed I will be a happy man.

ducatiman
30/10/2022
15:49
Hi Ducatiman, who knows?

14th February 2019, Dr Tom Oakley appointed CEO. So coming up to four years I thought it appropriate to look at the 4 year chart.

Approaching the low in that period of about 60p having been above £4 on two occasions. RSI is low but has been lower and fast stochastic is beginning to turn up. I'm betting on some news this week but be aware I have no charting skills. Where's SSB?

Are England a really good Rugby league team or just poor opposition so far? Looking forward to them being tested.

QPR going well, LR2.

Looked at the fundamentals, Pete. ADVFN still haven't corrected the mkt cap so deleted it again.

For the record it is £13.001M

ged5
30/10/2022
15:03
You could start end-2023 share price competition Duc. Put me down for £8.88.
lr2
30/10/2022
14:37
£93m PA revenue, where would that put the share price Ged?
Thanks for the post Ged.

ducatiman
25/10/2022
20:28
I've just updated the header, Yump whilst the grandkids watched the recording of Dr Who. There's a link to the September Investor Meet presentation. I think the roadshow is mentioned in that. Can't check at the moment.
ged5
25/10/2022
20:20
The AWS roadshow is inconsequential for FDBK.

AWS is seeking to develop its market. First step is offering a load of free services all over the place.

“Partner”; has so many meanings. I have a “partnership” with Google, as do a squillion other Adsense users.

yump
25/10/2022
19:50
Thanks for doing that, Pete.

The number of shares is correct. I copied that from the RNS. ADVFN still need to update the mkt cap.

I'll put the code in for the six month chart (when I relocate it) since I prefer to see the volume as well.

ged5
Chat Pages: Latest  556  555  554  553  552  551  550  549  548  547  546  545  Older

Your Recent History

Delayed Upgrade Clock